Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Pulmonary Sarcoidosis
NCT05910554Phase 2Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of metformin in pulmonary sarcoidosis, sponsored by University of Maryland, Baltimore. Planned start Dec 2025; status: withdrawn.
02
Drugs
metformin
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT05910554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05910554.